{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:07:06Z","timestamp":1772136426768,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-85388-2","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T19:18:01Z","timestamp":1736882281000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The use of the Prospector calculator reduces antibiotic therapy in exacerbations of chronic obstructive pulmonary disease"],"prefix":"10.1038","volume":"15","author":[{"given":"Marcin","family":"Paprocki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Szymon","family":"\u017bwirowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3205-3647","authenticated-orcid":false,"given":"Krzysztof","family":"Kuziemski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"issue":"7","key":"85388_CR1","first-page":"437","volume":"25","author":"YL Chan","year":"2002","unstructured":"Chan, Y. L. et al. C-Reactive protein as an indicator of bacterial infection of adult patients in the emergency department. Chang. Gung Med. J. 25 (7), 437\u2013445 (2002).","journal-title":"Chang. Gung Med. J."},{"key":"85388_CR2","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD): Global strategy for the diagnosis & management, and prevention of chronic obstructive pulmonary disease. (2023 REPORT) https:\/\/goldcopd.org\/. Accessed 10 November 2023."},{"issue":"5","key":"85388_CR3","doi-asserted-by":"publisher","first-page":"1900164","DOI":"10.1183\/13993003.00164-2019","volume":"53","author":"D Singh","year":"2019","unstructured":"Singh, D. et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: The GOLD science committee report 2019. Eur. Respir J. 53 (5), 1900164 (2019).","journal-title":"Eur. Respir J."},{"issue":"5","key":"85388_CR4","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1183\/09031936.02.00291302","volume":"19","author":"C Sohy","year":"2002","unstructured":"Sohy, C., Pilette, C., Niederman, M. S. & Sibille, Y. Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: What studies are still needed? Eur. Respir J. 19 (5), 966\u2013975 (2002).","journal-title":"Eur. Respir J."},{"issue":"6","key":"85388_CR5","doi-asserted-by":"publisher","first-page":"e20174124","DOI":"10.1542\/peds.2017-4124","volume":"141","author":"RM Zetts","year":"2018","unstructured":"Zetts, R. M., Stoesz, A., Smith, B. A. & Hyun, D. Y. Outpatient Antibiotic Use and the need for increased antibiotic stewardship efforts. Pediatrics 141 (6), e20174124 (2018).","journal-title":"Pediatrics"},{"issue":"2","key":"85388_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3855\/jidc.3573","volume":"8","author":"Z Golkar","year":"2014","unstructured":"Golkar, Z., Bagasra, O. & Pace, D. G. Bacteriophage therapy: A potential solution for the antibiotic resistance crisis. J. Infect. Dev. Ctries. 8 (2), 129\u2013136 (2014).","journal-title":"J. Infect. Dev. Ctries."},{"issue":"1","key":"85388_CR7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","volume":"19","author":"A Cassini","year":"2019","unstructured":"Cassini, A. et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: A population-level modelling analysis. Lancet Infect. Dis. 19 (1), 56\u201366 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"85388_CR8","unstructured":"Dobson, E. L. et al. SIDP Community Pharmacy Antimicrobial Stewardship Task Force. Outpatient antibiotic stewardship: Interventions and opportunities. J. Am. Pharm. Assoc. 57 (4), 464\u2013473. (2003)."},{"issue":"41","key":"85388_CR9","first-page":"679","volume":"117","author":"J Holstiege","year":"2020","unstructured":"Holstiege, J. et al. The decline in Outpatient Antibiotic Use. Dtsch. Arztebl Int. 117 (41), 679\u2013686 (2020).","journal-title":"Dtsch. Arztebl Int."},{"key":"85388_CR10","unstructured":"Bezpiecze\u0144stwo pacjent\u00f3w przy stosowaniu antybiotykoterapii w szpitalach. KZD.430.001.2019. Nr ewid. 40\/2019\/P\/18\/058\/KZD. March (2022). https:\/\/www.nik.gov.pl\/plik\/id,20833,v,artykul_19634.pdf. Accessed: 30."},{"issue":"1","key":"85388_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1465-9921-8-30","volume":"8","author":"MA Puhan","year":"2007","unstructured":"Puhan, M. A., Vollenweider, D., Latshang, T., Steurer, J. & Steurer-Stey, C. Exacerbations of chronic obstructive pulmonary disease: When are antibiotics indicated? A systematic review. Respir Res. 8 (1), 30 (2007).","journal-title":"Respir Res."},{"issue":"10","key":"85388_CR12","first-page":"CD010257","volume":"10","author":"DJ Vollenweider","year":"2018","unstructured":"Vollenweider, D. J., Frei, A., Steurer-Stey, C. A., Garcia-Aymerich, J. & Puhan, M. A. Antibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 10 (10), CD010257 (2018).","journal-title":"Cochrane Database Syst. Rev."},{"key":"85388_CR13","first-page":"A3118","volume":"183","author":"HJ Kwak","year":"2011","unstructured":"Kwak, H. J. et al. The role of viral infection in COPD exacerbation. B47. COPD EXACERBATIONS: MISCELLANEOUS. Am. J. Respir Crit. Care Med. 183, A3118 (2011).","journal-title":"Am. J. Respir Crit. Care Med."},{"issue":"1","key":"85388_CR14","first-page":"31","volume":"3","author":"A Siddiqi","year":"2008","unstructured":"Siddiqi, A. & Sethi, S. Optimizing antibiotic selection in treating COPD exacerbations. Int. J. Chron. Obstruct Pulmon Dis. 3(1), 31\u201344 (2008).","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"issue":"9","key":"85388_CR15","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1164\/rccm.201509-1869OC","volume":"193","author":"S Vedel-Krogh","year":"2016","unstructured":"Vedel-Krogh, S., Nielsen, S. F., Lange, P., Vestbo, J. & Nordestgaard, B. G. Blood eosinophils and exacerbations in chronic obstructive pulmonary disease. The copenhagen general population study. Am. J. Respir Crit. Care Med. 193 (9), 965\u2013974 (2016).","journal-title":"Am. J. Respir Crit. Care Med."},{"issue":"2","key":"85388_CR16","doi-asserted-by":"publisher","first-page":"196","DOI":"10.7326\/0003-4819-106-2-196","volume":"106","author":"NR Anthonisen","year":"1987","unstructured":"Anthonisen, N. R. et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann. Intern. Med. 106 (2), 196\u2013204 (1987).","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"85388_CR17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1177\/1753465812472387","volume":"7","author":"C Llor","year":"2013","unstructured":"Llor, C. et al. Predictors for antibiotic prescribing in patients with exacerbations of COPD in general practice. Ther. Adv. Respir Dis. 7 (3), 131\u2013137 (2013).","journal-title":"Ther. Adv. Respir Dis."},{"issue":"8","key":"85388_CR18","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1164\/rccm.200604-506OC","volume":"174","author":"JR Hurst","year":"2006","unstructured":"Hurst, J. R. et al. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. Am. J. Respir Crit. Care Med. 174 (8), 867\u2013874 (2006).","journal-title":"Am. J. Respir Crit. Care Med."},{"issue":"1","key":"85388_CR19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1164\/rccm.201108-1553OC","volume":"186","author":"M Bafadhel","year":"2012","unstructured":"Bafadhel, M. et al. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease. Am. J. Respir Crit. Care Med. 186 (1), 48\u201355 (2012).","journal-title":"Am. J. Respir Crit. Care Med."},{"issue":"6","key":"85388_CR20","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1183\/09031936.00150211","volume":"40","author":"N Soler","year":"2012","unstructured":"Soler, N. et al. Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD. Eur. Respir J. 40 (6), 1344\u20131353 (2012).","journal-title":"Eur. Respir J."},{"issue":"5","key":"85388_CR21","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1136\/thorax.56.5.366","volume":"56","author":"R Stockley","year":"2001","unstructured":"Stockley, R. et al. Assessment of airway neutrophils by sputum colour: Correlation with airways inflammation. Thorax 56 (5), 366\u2013372 (2001).","journal-title":"Thorax"},{"issue":"3","key":"85388_CR22","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1183\/09031936.05.00143404","volume":"26","author":"P Calverley","year":"2005","unstructured":"Calverley, P. et al. Relationship between respiratory symptoms and medical treatment in exacerbations of COPD. Eur. Respir J. 26 (3), 406\u2013413 (2005).","journal-title":"Eur. Respir J."},{"issue":"1","key":"85388_CR23","first-page":"61","volume":"88","author":"P Ball","year":"1995","unstructured":"Ball, P., Harris, J. M., Lowson, D., Tillotson, G. & Wilson, R. Acute infective exacerbations of chronic bronchitis. QJM 88 (1), 61\u201368 (1995).","journal-title":"QJM"},{"issue":"4","key":"85388_CR24","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1183\/09031936.00111707","volume":"31","author":"J Vestbo","year":"2008","unstructured":"Vestbo, J. et al. ECLIPSE investigators. Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE). Eur. Respir J. 31 (4), 869\u2013873 (2008).","journal-title":"Eur. Respir J."},{"issue":"4","key":"85388_CR25","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1136\/thx.2005.045930","volume":"61","author":"R Wilson","year":"2006","unstructured":"Wilson, R. et al. Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis. Thorax 61 (4), 337\u2013342 (2006).","journal-title":"Thorax"},{"key":"85388_CR26","first-page":"199","volume":"6","author":"BD Kent","year":"2011","unstructured":"Kent, B. D., Mitchell, P. D. & McNicholas, W. T. Hypoxemia in patients with COPD: Cause, effects, and disease progression. Int. J. Chron. Obstruct Pulmon Dis. 6, 199\u2013208 (2011).","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"key":"85388_CR27","first-page":"A3732","volume":"183","author":"JS Krahnke","year":"2011","unstructured":"Krahnke, J. S. et al. COPD patients with chronic purulent Sputum have more frequent COPD exacerbations and require more frequent treatment with antibiotics. B93. COPD EXACERBATIONS: IMPACT OF BACTERIAL AND VIRAL INFECTIONS. Am. J. Respir Crit. Care Med. 183, A3732 (2011).","journal-title":"J. Respir Crit. Care Med."},{"issue":"7","key":"85388_CR28","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1086\/423959","volume":"39","author":"P van der Valk","year":"2004","unstructured":"van der Valk, P. et al. Clinical predictors of bacterial involvement in exacerbations of chronic obstructive pulmonary disease. Clin. Infect. Dis. 39 (7), 980\u2013986 (2004).","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"85388_CR29","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00134-002-1209-6","volume":"28","author":"P P\u00f3voa","year":"2002","unstructured":"P\u00f3voa, P. C-reactive protein: A valuable marker of sepsis. Intensive Care Med. 28 (3), 235\u2013243 (2002).","journal-title":"Intensive Care Med."},{"key":"85388_CR30","unstructured":"Cals, J. W. L. C-reactive protein point-of-care testing for respiratory-tract infections in primary care. (2012). https:\/\/acutecaretesting.org\/-\/media\/acutecaretesting\/files\/pdf\/creactive-protein-pointofcare-testing-for-respiratorytract-infections-in-primary-care.pdf Accessed: 30 March 2022."},{"issue":"9","key":"85388_CR31","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.aprim.2014.02.006","volume":"46","author":"C Llor","year":"2014","unstructured":"Llor, C. et al. Effectiveness of two types of intervention on antibiotic prescribing in respiratory tract infections in primary care in Spain. Happy Audit Study Atenci\u00f3n Primaria. 46 (9), 492\u2013500. https:\/\/doi.org\/10.1016\/j.aprim.2014.02.006 (2014).","journal-title":"Happy Audit Study Atenci\u00f3n Primaria"},{"issue":"suppl_3","key":"85388_CR32","doi-asserted-by":"publisher","first-page":"S378","DOI":"10.1093\/cid\/cix150","volume":"64","author":"MM Higdon","year":"2017","unstructured":"Higdon, M. M. et al. Association of C-reactive protein with bacterial and respiratory syncytial virus\u2013associated pneumonia among children aged\u2009<\u20095 years in the PERCH study Clin. Infect. Dis. 64 (suppl_3), S378\u2013S386 (2017).","journal-title":"Clin. Infect. Dis."},{"issue":"Suppl 3","key":"85388_CR33","doi-asserted-by":"publisher","first-page":"A1","DOI":"10.1136\/thoraxjnl-2016-209333.286","volume":"71","author":"RE Villalobos","year":"2016","unstructured":"Villalobos, R. E., Magallanes, J. & David-Wang, A. P143 blood eosinophilia as predictor for patient outcomes in COPD exacerbations: A systematic review and meta-analysis. Thorax 71 (Suppl 3), A1\u2013A288 (2016).","journal-title":"Thorax"},{"key":"85388_CR34","doi-asserted-by":"publisher","first-page":"j1415","DOI":"10.1136\/bmj.j1415","volume":"357","author":"AK Waljee","year":"2017","unstructured":"Waljee, A. K. et al. Short term use of oral corticosteroids and related harms among adults in the United States: Population based cohort study. BMJ 357, j1415 (2017).","journal-title":"BMJ"},{"issue":"26","key":"85388_CR35","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1056\/NEJMoa023161","volume":"348","author":"SD Aaron","year":"2003","unstructured":"Aaron, S. D. et al. Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. N Engl. J. Med. 348 (26), 2618\u20132625 (2003).","journal-title":"N Engl. J. Med."},{"issue":"8","key":"85388_CR36","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1164\/rccm.201412-2269OC","volume":"192","author":"GC Donaldson","year":"2015","unstructured":"Donaldson, G. C. et al. Impact of prolonged exacerbation recovery in chronic obstructive pulmonary disease. Am. J. Respir Crit. Care Med. 192 (8), 943\u2013950 (2015).","journal-title":"Am. J. Respir Crit. Care Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85388-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85388-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85388-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T19:18:07Z","timestamp":1736882287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85388-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["85388"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-85388-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4295196\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"19 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval received from Bioethics Committee of District Medical Chamber in Gda\u0144sk\n                      \n                      Approval number: KB \u2013 14\/2\/15.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1969"}}